The inherited progressive disorder cystic fibrosis (CF) causes severe damage to the lungs, and other tissues in the body by affecting the cells that produce mucus, sweat, and digestive juices. In individuals carrying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes an ion channel controlling the...
research News
BETHESDA, Md. — The Cystic Fibrosis Foundation announced that it will provide up to $15 million to Prime Medicine for preclinical research into gene editing for cystic fibrosis. Prime Medicine is using a gene editing technology called prime editing — a technology that enables insertions or deletions of small segments of...
VANCOUVER, Wash. — CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the Company has submitted its revised HIV clinical trial protocol to the FDA. The Company believes this submission will lead to the removal of the...
Sydney, Australia – In good news for office workers, a new study from the University of Sydney’s Charles Perkins Centre has found increasing your step count may counteract the health consequences of too much sedentary time each day. The study of over 72,000 people, published in the British Journal of...
Boston, MA — Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known as SWIFT-seq, utilizes single-cell sequencing to profile circulating tumor cells (CTCs) in the blood, offering a non-invasive alternative to traditional...
Boston, Mass. – Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia (APL) and chronic myeloid leukemia (CML) in...
SAN FRANCISCO, Calif. — Today marks a turning point in the battle against Alzheimer’s disease as Darmiyan, Inc., a leading company in brain health innovation announces the FDA’s approval of its first-in-class (De Novo) clinical test, BrainSee. This approval marks a pivotal advancement in brain health and opens the door to...
Hanover, New Hampshire – Findings from a new study conducted by a team of researchers at Dartmouth’s Geisel School of Medicine and Thayer School of Engineering and published in Cell Reports Medicine, offer new insights into how antibodies function in combating herpes simplex virus (HSV) infections. Their research may lead to possible...
HANOVER, New Hampshire – Among people with cystic fibrosis (CF) who develop kidney failure, getting a kidney transplant may extend survival by nearly two decades compared with other types of care, a new study found. The transplanted kidneys also showed favorable long-term outcomes in people with CF, remaining functional for about...
HANOVER, New Hampshire – Adults with cystic fibrosis (CF) who spent more time exposed to elevated levels of indoor fine particulate matter showed changes in certain blood proteins involved in inflammation and tissue repair, according to a pilot study. The findings suggest that short-term exposure to indoor air pollution may...
